Health-related quality of life in esophageal cancer: Effect of neoadjuvant chemoradiotherapy followed by surgical intervention

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 1, 2009, Pages 36-42

  Safieddine, Najib ^a   Xu, Wei ^b   Quadri, Sayed Mohammed ^c   Knox, Jennifer J ^d   Hornby, Jennifer ^a   Sulman, Joanne ^b   Wong, Rebecca ^d   Guindi, Maha ^d   Keshavjee, Shaf ^a   Darling, Gail ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IRINOTECAN;

ADJUVANT CHEMOTHERAPY; ANOREXIA; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CLINICAL TRIAL; DIARRHEA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FATIGUE; FEBRILE NEUTROPENIA; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 58249086538     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.09.049     Document Type: Article

References (22)

1. Darling G., Eton D., Sulman J., Casson A., and Cella D. Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer 107 (2006) 854-863
2. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240 (2004) 962-972
3. Alexiou C., Khan O.A., Black E., et al. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Ann Thorac Surg 82 (2006) 1073-1077
4. Fok M., and Wong J. Cancer of the oesophagus and gastric cardia. Standard oesophagectomy and anastomotic technique. Ann Chir Gynaecol 84 (1995) 179-183
5. Visbal A.L., Allen M.S., Miller D.L., Deschamps C., Trastek V.F., and Pairolero P.C. Ivor Lewis esophagectomy for esophageal cancer. Ann Thorac Surg 71 (2001) 1803-1808
6. Swanson S.J., Batirel H.F., Jalitsch M.T., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymphnode dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 72 (2001) 1918-1924
7. Swisher S.G., Holmes E.C., Hunt K.K., et al. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 131 (1996) 819-824
8. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy P.J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 33 (1996) 462-467
9. Urschel J.D., Vasan H., and Blewett C.J. A meta analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183 (2002) 274-279
10. Malaiserie S.C., Untch B., and Aranha G.V. Neoadjuvant chemoradiation for locally advanced esophageal cancer: experience at a single institution. Arch Surg 139 (2004) 532-538
11. Tamim W.Z., Davidson R.S., Quinlan R.M., et al. Neoadjuvant chemotherapy for esophageal cancer: is it worthwhile?. Arch Surg 133 (1998) 722-726
12. Knox J., Darling G., Guindi M., et al. A phase II study to assess the efficacy of combined preoperative irinotican I/cisplatin (C) chemotherapy and conformal radiotherapy (RT) followed by surgery for potentially resectable esophageal cancer. J Clin Oncol 22 14S (2004) 4063
13. Blazeby J.M., Conroy T., Hammerlid F., et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life of patients with oesophageal cancer. Eur J Cancer 39 (2003) 1384-1394
14. Blazeby J.M., Farndon J.R., Donovan J., and Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88 (2000) 1781-1787
15. Viklund P., Wengstrom Y., Rouvelas I., Lindblad M., and Lagergren J. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 42 (2006) 1407-1414
16. Brooks J.A., Kesler K.A., Johnson C.S., Ciatta D., and Brown J.W. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 81 (2002) 185-194
17. de Boer A.G., van Lanschot J.J., van Sandick J.W., et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 22 (2004) 4202-4208
18. Viklund P., Lindblad M., and Lagergren J. Influence of surgery related factors on quality of life after esophageal or cardia cancer resection. World J Surg 29 (2005) 841
19. Bottomley A., Flechtner H., Efficace F., et al. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 41 (2005) 1697-1709
20. Reynolds J.V., McLaughlin R., Moore J., Rowley S., Ravi N., and Byrne P.J. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 93 (2006) 1084-1090
21. Bonnetain F., Bouche O., Michel P., et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17 (2006) 827-834
22. Fang F.M., Tsai W.L., Chiu H.C., Kuo W.R., and Hsiung C.Y. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol 58 (2004) 1394-1404